Every year, major healthcare companies get an opportunity to tell their story at the J.P. Morgan Healthcare Conference. At this year's conference, Gilead Sciences' (NASDAQ: GILD) story sounded better than it has in quite a while.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,